Robert S. Rosenson
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
-
- Lipid metabolism and disorders
- Antiplatelet Therapy and Cardiovascular Diseases
Papers in
- Surgery 240
- Lipoproteins and Cardiovascular Health 220
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 86
- Co-authors
- Christy Tangney (27 shared papers)James Dorian Otvos (11 shared papers)H. Bryan Brewer (7 shared papers)Paul Muntner (65 shared papers)Daniel Gaudet (24 shared papers)Anatol Kontush (4 shared papers)Wolfgang Köenig (11 shared papers)Alan R. Tall (3 shared papers)
- Journals
- Journal of the American College of Cardiology (53 papers)Cardiovascular Drugs and Therapy (42 papers)Atherosclerosis (32 papers)Journal of clinical lipidology (23 papers)The American Journal of Cardiology (15 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Robert S. Rosenson
409 papers receiving 21.5k citations
Robert S. Rosenson's Hit Papers
Peers
Comparison fields: 5 of 178
- Endocrinology, Diabetes and Metabolism 4.6k
- Cardiology and Cardiovascular Medicine 4.9k
- Surgery 9.4k
- Cancer Research 1.9k
- Immunology 1.4k
Countries citing papers authored by Robert S. Rosenson
This map shows the geographic impact of Robert S. Rosenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Rosenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Rosenson more than expected).
Fields of papers citing papers by Robert S. Rosenson
This network shows the impact of papers produced by Robert S. Rosenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Rosenson. The network helps show where Robert S. Rosenson may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert S. Rosenson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 428 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension Hit paper breakdown → | 2009 | 936 |
| 2 | Cholesterol Efflux and Atheroprotection Hit paper breakdown → | 2012 | 821 |
| 3 | Antiatherothrombotic Properties of Statins Hit paper breakdown → | 1998 | 815 |
| 4 | Dysfunctional HDL and atherosclerotic cardiovascular disease Hit paper breakdown → | 2015 | 633 |
| 5 | Evinacumab for Homozygous Familial Hypercholesterolemia Hit paper breakdown → | 2020 | 589 |
| 6 | Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance Hit paper breakdown → | 2014 | 463 |
| 7 | Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance Hit paper breakdown → | 2016 | 437 |
| 8 | HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events Hit paper breakdown → | 2011 | 424 |
| 9 | 2009 | 422 | |
| 10 | Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease Hit paper breakdown → | 2022 | 421 |
| 11 | 2008 | 393 | |
| 12 | 2006 | 389 | |
| 13 | 1999 | 340 | |
| 14 | 2012 | 324 | |
| 15 | 2008 | 319 | |
| 16 | Deep learning for cardiovascular medicine: a practical primer Hit paper breakdown → | 2019 | 297 |
| 17 | 2013 | 281 | |
| 18 | 2014 | 274 | |
| 19 | Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction Hit paper breakdown → | 2017 | 274 |
| 20 | 2002 | 248 |
About Robert S. Rosenson
Robert S. Rosenson is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Cancer Research and Pulmonary and Respiratory Medicine, having authored 428 papers that have together received 22.4k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (220 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (86 papers), Cancer, Lipids, and Metabolism (43 papers), Lipid metabolism and disorders (41 papers), Blood properties and coagulation (29 papers), Health Systems, Economic Evaluations, Quality of Life (26 papers), Pharmaceutical Economics and Policy (25 papers) and Antiplatelet Therapy and Cardiovascular Diseases (19 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.6k citations), Cardiology and Cardiovascular Medicine (4.9k citations), Surgery (9.4k citations), Cancer Research (1.9k citations) and Immunology (1.4k citations). Robert S. Rosenson has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Christy Tangney, James Dorian Otvos, H. Bryan Brewer, Paul Muntner, Daniel Gaudet, Anatol Kontush, Wolfgang Köenig, Alan R. Tall, M. John Chapman and Philip J. Barter. Their work appears in journals such as Journal of the American College of Cardiology, Cardiovascular Drugs and Therapy, Atherosclerosis, Journal of clinical lipidology and The American Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.